Earnings Call · Q2 FY2024·2024-01-24

Q2 24EPS +5.26%·Rev n/aQ1 24EPS +2.50%·Rev n/aQ4 23EPS 0.00%·Rev n/aQ3 23EPS -1.18%·Rev n/a⚠ consensus missing

RESMED INC RSMDF

Amy Wakeham — Investor Relations or Corporate Communications

Michael Farrell — Chief Executive Officer (CEO)

Brett Sandercock — Chief Financial Officer (CFO)

+14.0%1d on move date+7.5% vs SPY3d+18.1%5d+9.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RSMDF calls or request research access.

More RSMDF calls Browse calls Request research access